- Home
- RDVT vs ARCT Comparison
RDVT vs ARCT Comparison
Compare RDVT & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDVT
- ARCT
- Stock Information
- Founded
- RDVT 2017
- ARCT 2013
- Country
- RDVT United States
- ARCT United States
- Employees
- RDVT N/A
- ARCT N/A
- Industry
- RDVT Computer Software: Prepackaged Software
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- RDVT Technology
- ARCT Health Care
- Exchange
- RDVT Nasdaq
- ARCT Nasdaq
- Market Cap
- RDVT 538.6M
- ARCT 444.5M
- IPO Year
- RDVT N/A
- ARCT N/A
- Fundamental
- Price
- RDVT $36.72
- ARCT $10.53
- Analyst Decision
- RDVT
- ARCT Strong Buy
- Analyst Count
- RDVT 0
- ARCT 7
- Target Price
- RDVT N/A
- ARCT $57.80
- AVG Volume (30 Days)
- RDVT 79.2K
- ARCT 462.9K
- Earning Date
- RDVT 05-07-2025
- ARCT 05-07-2025
- Dividend Yield
- RDVT 0.81%
- ARCT N/A
- EPS Growth
- RDVT N/A
- ARCT N/A
- EPS
- RDVT 0.50
- ARCT N/A
- Revenue
- RDVT $75,189,000.00
- ARCT $152,310,000.00
- Revenue This Year
- RDVT $15.93
- ARCT N/A
- Revenue Next Year
- RDVT $13.85
- ARCT $39.21
- P/E Ratio
- RDVT $73.63
- ARCT N/A
- Revenue Growth
- RDVT 24.89
- ARCT N/A
- 52 Week Low
- RDVT $16.56
- ARCT $8.04
- 52 Week High
- RDVT $43.44
- ARCT $45.00
- Technical
- Relative Strength Index (RSI)
- RDVT 47.11
- ARCT 43.14
- Support Level
- RDVT $36.16
- ARCT $10.07
- Resistance Level
- RDVT $37.93
- ARCT $11.00
- Average True Range (ATR)
- RDVT 2.26
- ARCT 0.88
- MACD
- RDVT 0.02
- ARCT 0.26
- Stochastic Oscillator
- RDVT 64.23
- ARCT 77.81
About RDVT Red Violet Inc.
Red Violet Inc is a software and services company. It specializes in big data analysis, providing cloud-based, mission-critical information solutions to enterprises in a variety of industries. Through its CORE data fusion platform, it provides mission-critical information about individuals, businesses and assets.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.